FibroGen Inc (FGEN) is a biotechnology company listed on NASDAQ.
Latest reported FGEN revenue for 2024-12-31 was $29.6M. Net income was -$47.6M. Revenue was down 36.7% from 2023-12-31 to 2024-12-31. FGEN currently screens at market cap $39.3M.
Use this FGEN page for company research — sector, financials, and the latest filing takeaway — not a live tape. The session quote (last, range, volume) lives on the FGEN quote page. Cached 10-K, 10-Q, 8-K, and Form 4 exhibits are on the FGEN SEC filings page. Lician reads the product cache first so this HTML stays unique to FibroGen Inc even when a live quote feed is slow.
Latest cached year on this hub. Full FGEN income, balance, and cash tables.